Gujarat Alkalies reported a significant jump in standalone profit to ₹53.40 crore for the quarter ending June 30, 2026, up from ₹7.79 crore year-on-year. The company also approved a new ₹55 crore HCL synthesis unit at its Dahej facility.
Detailed Coverage
Gujarat Alkalies Posts Strong Profit Growth, Approves New Project
Gujarat Alkalies and Chemicals Ltd has reported a standalone profit after tax of ₹53.40 crore for the quarter ended June 30, 2026. This marks a substantial increase from ₹7.79 crore in the same quarter last year. The company's standalone revenue also grew to ₹1244.91 crore from ₹1105.12 crore.
Reader Takeaway: Strong profit recovery driven by operational efficiency; new project signals future growth.
What just happened
Gujarat Alkalies and Chemicals Ltd (GACL) announced its financial results for the quarter ending June 30, 2026. The company's standalone profit after tax (PAT) surged to ₹53.40 crore, a significant jump from ₹7.79 crore in the corresponding quarter of the previous year. Standalone revenue from operations also saw a healthy rise, reaching ₹1244.91 crore compared to ₹1105.12 crore in the prior year's quarter.
The Board of Directors has also given in-principle approval to set up a new Hydrochloric Acid (HCL) synthesis unit at its Dahej facility. This project is estimated to cost approximately ₹55 crore and aims to improve chlorine utilization and optimize Caustic Soda production. The generated HCL will be used in the already approved Phosphoric Acid plant.
Why this matters
The strong profit growth indicates improved operational performance and effective cost management by the company. The approval of the new HCL synthesis unit signals GACL's commitment to strategic expansion and vertical integration, which could lead to enhanced product utilization and profitability in the long term.
The backstory
Gujarat Alkalies and Chemicals Ltd is a major producer of caustic soda and its allied chemicals in India. The company has been focused on expanding its capacities and diversifying its product portfolio. The Dahej facility is a key operational hub for the company.
What changes now
With the approval of the new HCL synthesis unit, GACL is set to enhance its operational efficiency and chlorine utilization. This investment of ₹55 crore is expected to strengthen its position in the chemical sector and contribute to future revenue streams. The improved profitability in the current quarter provides a positive outlook for investors.
Risks to watch
The company's statutory auditor has highlighted an 'Emphasis of Matter' concerning differential energy charges. GACL recognized a one-time charge of ₹16.65 crore for these charges payable to GUVL for the period between 2018 and 2023. While this charge impacted the current quarter's profitability, it relates to past periods.
Peer comparison
While specific peer results for the same period are not detailed in the filing, GACL's performance shows a significant year-on-year improvement in profitability. Investors will be looking at how other major chemical manufacturers perform to gauge industry trends.
Context metrics (time-bound)
- Revenue from Operations (Standalone): ₹1244.91 crore (Quarter ended June 30, 2026) vs. ₹1105.12 crore (Quarter ended June 30, 2025).
- Profit after Tax (Standalone): ₹53.40 crore (Quarter ended June 30, 2026) vs. ₹7.79 crore (Quarter ended June 30, 2025).
- New Project Cost: ₹55 crore (HCL Synthesis Unit).
- Differential Energy Charges: ₹16.65 crore (one-time charge for 2018-2023).
What to track next
Investors should track the progress of the new HCL synthesis unit's construction and commissioning. Monitoring future quarterly results for sustained profit growth and managing the impact of any further energy-related cost adjustments will be crucial.
